News from RPS, INC Research and AMRI – People on the move
Outsourcing-Pharma presents its weekly round-up of the latest comings and goings in the pharmaceutical industry including news from RPS, INC Research and AMRI.
Archives for April 16, 2012
Catalent signs combined cell development and Ab manufacturing deal
Catalent has signed a cell line development deal with Nascent Biologics, further underlining its interest in biologics-focused contracting.
Survey results add to hopes of drug discovery outsourcing rise
Positive survey results have added to evidence that outsourcing of drug discovery can partly offset weakness in GLP toxicology.
Ashland launches integrated tablet excipients pipeline
More post-acquisition integration in the pharma excipients space this week with Ashland launching a new product line combining its own techs with coatings it bought with International Specialty Products (ISP) in 2011.
EMA posts guideline to support continuous process verification
The EMA has released draft continuous process verification guidelines to bring its policies in line with ICH Q8, Q9 and Q10.
Novo Nordisk warns FDA of biosimilar delivery safety fears
Novo Nordisk has told the FDA allowing alternative delivery devices for biosimilars creates “significant safety implications”.
Bosch completes Eisai Machinery takeover
Bosch Packaging Technologies has completed the acquisition of Eisai’s machinery business, expanding its inspection technology portfolio.